The therapeutic potential of a series of orally bioavailable anti-angiogenic microtubule disruptors as therapy for hormone-independent prostate and breast cancers.

MLA

Newman, S. P., et al. “The Therapeutic Potential of a Series of Orally Bioavailable Anti-Angiogenic Microtubule Disruptors as Therapy for Hormone-Independent Prostate and Breast Cancers.” British Journal of Cancer, vol. 97, no. 12, Dec. 2007, pp. 1673–82. EBSCOhost, https://doi.org/10.1038/sj.bjc.6604100.

APA

Newman, S. P., Foster, P. A., Ho, Y. T., Day, J. M., Raobaikady, B., Kasprzyk, P. G., Leese, M. P., Potter, B. V. L., Reed, M. J., & Purohit, A. (2007). The therapeutic potential of a series of orally bioavailable anti-angiogenic microtubule disruptors as therapy for hormone-independent prostate and breast cancers. British Journal of Cancer, 97(12), 1673–1682. https://doi.org/10.1038/sj.bjc.6604100

Chicago

Newman, S P, P A Foster, Y T Ho, J M Day, B Raobaikady, P G Kasprzyk, M P Leese, B V L Potter, M J Reed, and A Purohit. 2007. “The Therapeutic Potential of a Series of Orally Bioavailable Anti-Angiogenic Microtubule Disruptors as Therapy for Hormone-Independent Prostate and Breast Cancers.” British Journal of Cancer 97 (12): 1673–82. doi:10.1038/sj.bjc.6604100.